AI Predicts Alzheimer’s Seven Years in Advance

In a groundbreaking development that feels like it’s straight out of a sci-fi novel, scientists from the University of California, San Francisco (UCSF), have harnessed the power of artificial intelligence (AI) to predict Alzheimer’s disease up to seven years before the onset of symptoms. This innovative approach, which was recently published in the prestigious journal Nature Aging, signifies a monumental leap forward in our quest to combat this devastating disease.

Alzheimer’s disease, a form of dementia that gradually erodes memory and cognitive abilities, currently affects an estimated 6.7 million Americans, with a disproportionately higher number of cases found in women. Traditionally, the diagnosis of Alzheimer’s comes too late in the disease’s progression, when symptoms are already evident and the opportunity for early intervention has passed. However, the UCSF team’s research offers a beacon of hope, utilizing machine learning to sift through vast amounts of patient data to identify potential early indicators of the disease.

The AI model developed by the researchers zeroes in on specific conditions that elevate the risk of Alzheimer’s. High cholesterol levels emerged as a significant predictor for both genders, while osteoporosis, a condition that weakens bones and is more prevalent in older women, was identified as a particularly strong indicator for females. It’s important to note, however, that not everyone with osteoporosis will develop Alzheimer’s, but the presence of such conditions in tandem with others may heighten the risk.

Alice Tang, an MD/PhD student and the study’s lead author, emphasizes the innovative aspect of their approach: “This is a first step towards using AI on routine clinical data, not only to identify risk as early as possible, but also to understand the biology behind it.” The team’s method relies on identifying risk through the combination of different diseases, rather than isolating single conditions.

The scientists employed UCSF’s clinical database, comprising over 5 million patients, to compare those diagnosed with Alzheimer’s at the UCSF Memory and Aging Center against individuals without the disease. Their analysis boasted a 72% success rate in predicting Alzheimer’s development up to seven years before traditional diagnostic methods would catch it.

Beyond prediction, the team sought to unravel the biological underpinnings of these predictors. Using public molecular databases alongside UCSF’s own Scalable Precision Medicine Oriented Knowledge Engine (SPOKE), they discovered genetic links that could explain the association between Alzheimer’s, high cholesterol, and, intriguingly, osteoporosis in women.

The implications of this research are vast, opening doors to earlier diagnosis, more effective treatment, and even the prevention of Alzheimer’s. Moreover, this approach has the potential to revolutionize the diagnosis and treatment of other complex diseases, such as lupus and endometriosis, by harnessing the predictive power of AI in analyzing clinical data.

Funded primarily by the National Institute on Aging, this study stands as a testament to the potential of combining machine learning with healthcare data to illuminate the complex pathways leading to Alzheimer’s and other diseases. As we continue to explore the capabilities of AI in medicine, we edge closer to a future where diseases like Alzheimer’s can be predicted, prevented, and perhaps even eradicated before they take hold.

Source: “Leveraging electronic health records and knowledge networks for Alzheimer’s disease prediction and sex-specific biological insights” 21 February 2024, Nature Aging.
DOI: 10.1038/s43587-024-00573-8

---

Like this article?  Keep up to date with AI news, apps, tools and get tips and tricks on how to improve with AI.  Sign up to our Free AI Newsletter

Also, come check out our free AI training portal and community of business owners, entrepreneurs, executives and creators. Level up your business with AI ! New courses added weekly.